Transcatheter Aortic Valve Implantation (TAVI) Market Set to Quadruple to $16.9 Billion by 2030

Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during the forecast period.

PORTLAND, OR, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “Transcatheter Aortic valve Implantation (TAVI) Market by Procedure Type: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global TAVI market was valued at $4.56 billion in 2020, and is estimated to reach $16.94 billion by 2030, growing at a CAGR of 14.0% from 2021 to 2030.

Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive procedure to replace a thickened aortic valve. TAVI helps restore blood flow and reduce signs and symptoms of aortic valve stenosis such as shortness of breath, depression, fatigue, and chest pain. Factors driving the growth of the global transcatheter aortic valve implantation market include the rise in aortic stenosis, advances in transcatheter aortic valves, and increasing adoption of TAVI valves.

► Don't Miss Out “Download Your Exclusive Sample PDF Report” Now:
https://www.alliedmarketresearch.com/request-sample/1675

Key Benefits for Stakeholders -

• The report provides quantitative analysis of market segments, current trends, strategies and potential of transcatheter aortic valve implantation market research to identify potential transcatheter aortic valve implantation market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided.
• Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global transcatheter aortic valve implantation market analysis, key players, market segments, application areas and Market growth strategies.

Major market players covered in the report -

• Abbott Laboratories
• Boston Scientific Corporation
• Blue Sail Medical Co. Ltd.
• Bracco
• Edward Lifesciences
• JC Medical Inc.
• JenaValve Techologies Inc.
• Medtronic Plc
• Meril Lifesciences
• Venus Medtech

★ Procure Complete Report [ 220 Pages PDF with Insights, Charts, Tables, and Figures ] @
https://www.alliedmarketresearch.com/purchase-enquiry/1675

Europe accounted for the largest share of the global Transcatheter Aortic Valve Implantation (TAVI) market in 2020 and is expected to remain dominant during the forecast period. This is due to the increasing prevalence of aortic stenosis and the high rate of adoption of transcatheter aortic valves in this area. In addition, favourable reimbursement policies in some European countries are the main factors increasing the acceptance of the TAVI procedure in this region.

TABLE OF CONTENT -

CHAPTER 1 - INTRODUCTION:
1.1. Report description
1.2. Key market segments
1.3. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 - EXECUTIVE SUMMARY:
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3 - MARKET OVERVIEW:
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis/Top Player Positioning
3.4. Porter’s Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities…
3.6. COVID-19 Impact Analysis on the market

However, Asia-Pacific is expected to be the fastest growing region (in terms of value and volume) throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of aortic stenosis.